RAYMOND JAMES & ASSOCIATES - EDITAS MEDICINE INC ownership

EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 315 filers reported holding EDITAS MEDICINE INC in Q4 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of EDITAS MEDICINE INC
ValueSharesWeighting
Q3 2023$2,139,563
+0.3%
274,303
+5.8%
0.00%0.0%
Q2 2023$2,134,113
+181.0%
259,309
+147.6%
0.00%
+100.0%
Q1 2023$759,387
-11.9%
104,743
+7.7%
0.00%0.0%
Q4 2022$862,403
-18.0%
97,227
+13.2%
0.00%0.0%
Q3 2022$1,052,000
-35.8%
85,908
-38.0%
0.00%
-50.0%
Q2 2022$1,638,000
-47.8%
138,479
-28.7%
0.00%
-33.3%
Q1 2022$3,135,000
+99.7%
194,221
+228.4%
0.00%
+200.0%
Q4 2021$1,570,000
-40.1%
59,150
-7.4%
0.00%
-50.0%
Q3 2021$2,623,000
-36.8%
63,861
-33.1%
0.00%
-50.0%
Q2 2021$4,151,000
+18.8%
95,463
-14.8%
0.00%
+33.3%
Q1 2021$3,493,000
-18.8%
112,027
+82.6%
0.00%
-40.0%
Q4 2020$4,301,000
+88.0%
61,342
-24.8%
0.01%
+66.7%
Q3 2020$2,288,000
-22.7%
81,534
-18.5%
0.00%
-25.0%
Q2 2020$2,959,000
+57.6%
100,036
+5.7%
0.00%
+33.3%
Q1 2020$1,877,000
+21.1%
94,656
+80.9%
0.00%
+50.0%
Q4 2019$1,550,000
+13.3%
52,338
-13.0%
0.00%0.0%
Q3 2019$1,368,000
-6.0%
60,144
+2.2%
0.00%0.0%
Q2 2019$1,456,000
+254.3%
58,848
+250.3%
0.00%
+100.0%
Q1 2019$411,000
-36.3%
16,798
-40.7%
0.00%0.0%
Q4 2018$645,000
-40.0%
28,346
-16.1%
0.00%
-50.0%
Q3 2018$1,075,000
-7.0%
33,778
+4.7%
0.00%0.0%
Q2 2018$1,156,000
+8.6%
32,273
+0.5%
0.00%0.0%
Q1 2018$1,064,00032,1010.00%
Other shareholders
EDITAS MEDICINE INC shareholders Q4 2020
NameSharesValueWeighting ↓
Deep Track Capital, LP 7,101,935$55,395,0932.14%
Green Alpha Advisors, LLC 77,188$602,0660.46%
Woodline Partners LP 3,259,710$25,425,7380.30%
TANG CAPITAL MANAGEMENT LLC 200,000$1,560,0000.22%
Spectrum Planning & Advisory Services Inc. 14,038$109,4960.17%
PDT Partners, LLC 156,515$1,220,8170.15%
CALTON & ASSOCIATES, INC. 13,420$104,6760.15%
Corton Capital Inc. 29,365$229,0470.12%
CAXTON ASSOCIATES LP 61,223$477,5390.07%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 119,287$930,4390.06%
View complete list of EDITAS MEDICINE INC shareholders